Clinical Trial Update: Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating maintenance therapy with autologous cytokine-induced killer cells for small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Autologous cytokine-induced killer cells (cytokine-induced killer cells)

Snippet

Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN